Case Study: a leading pharma company achieves record-breaking global vaccine safety monitoring with Linguamatics

Safety program for COVID-19 vaccine a blueprint for global safety agility

a leading pharma company and its pharmacovigilance provider faced an immense challenge in monitoring the safety of its COVID-19 vaccine. They needed to manage a record-breaking, rapid scale-up in adverse event reports across 55 languages, all under intense regulatory scrutiny and tight deadlines due to the global pandemic.

Linguamatics implemented its end-to-end language solution, leveraging its specialized clinical Machine Translation engine and its Linguamatics hub platform for 24/7 project management. This deep integration saved time and money while ensuring on-time delivery and outperforming other providers. The Linguamatics solution successfully enabled a global safety program under these extraordinary conditions.